Banner Picture
           

about me

Lee Crandall Park, M.D.
Veritas, Vos, Liberabit
(The truth shall make you free)
— motto of Johns Hopkins University


Lux et Veritas
(Light and truth)

— motto of Yale University

Lee Crandall Park, M.D.
Aequanimitas
Sir William Osler,
Knighted in 1911

CURRICULUM VITAE
Last updated August 2002

(You may download an Adobe Acrobat version of this curriculum vitae for printing.)

Choose to view:

LECTURES, SEMINARS, INTERVIEWS AND PRESENTATIONS:

  1. The Antidepressive Drugs: A Tentative Appraisal of Their Usefulness and Limitations", Johns Hopkins Medical Institutions, Postgraduate Program. Hurd Hall, l961.
  2. "Drug Abuse", The Park School, Brooklandville, MD., l963.
  3. "Psychiatry for the Internist", American College of Physicians, University of Maryland, l964.
  4. "Emotional Problems of the College Student", Panel Discussion presented by Mount Saint Agnes College, WBAL-TV, Baltimore, March 15, l964.
  5. "Symptom and Nonsympton Focused Criteria of Outpatient Drug Efficacy, 118th Annual Meeting, American Psychiatric Assn., NY, May, 1965.
  6. Discussant: "Placebo Effects, Factors Influencing Subjective Response, and the Relationships between Psychotherapy and Psychotropic Drugs", Clinical Psychopharmacology Seminars, Johns Hop. Hosp., l966.
  7. Effects of Informed Consent on Research Patients and Study Results", 120th Annual Meeting, American Psychiatric Assn., Detroit, MI, May, l967.
  8. "Ethics of Human Experimentation", Conjoint Clinic, Turner Auditorium, Johns Hopkins Hosp., l969.
  9. "Problems in Clinical Psychopharmacological Research", National Naval Medical Center, Bethesda, l969.
  10. Discussant: "Biochemical Aspects of Clinical Psychopharmacology", 123rd Annual Meeting, American Psychiatric Assn., San Francisco, CA, l970.
  11. The Evaluation of Brief Psychotherapy", Psychiatric Liaison Service, Johns Hopkins Hospital, l970.
  12. "Patient Preparation for Brief Psychotherapy", Psychiatric Liaison Service, Johns Hopkins Hospital, l97l.
  13. "Non-Specific Factors in Psychotherapy", Seminars in Psychosomatic Medicine, Johns Hop. Hosp., l97l.
  14. "Tribute to Jerome D. Frank", Scientific Program in Honor of Dr. Frank at his retirement, Hurd Hall Auditorium, Johns Hopkins Hospital, Oct. l9, l974.
  15. "Emotional Problems of Adolescence", St. Paul's School, Brooklandville, Md., April, l977.
  16. "Heinz Kohut", The Henry Phipps Psychiatric Clinic, Johns Hopkins Hospital, Nov.30, l983.
  17. "Heinz Kohut, Otto Kernberg and Jacques Lacan", The Henry Phipps Psychiatric Clinic, Johns Hopkins Hospital, Oct. l7 and 24, l984.
  18. "The Gifted Borderline: An Heuristic Hypothesis for New Directions in Research", Department of Psychology, University of Texas, Austin, Texas, March 9, 1990.
  19. "Giftedness and Psychological Abuse in BPD", 145th Annual Mtng., Am. Psychiatric Assn., Wash. D.C., May, 1992.
  20. "The Child Abuse and Neglect Movement: The New Emphasis on Emotional and Verbal Abuse", Radio WCTR-AM, Chestertown, Md., June 1992.
  21. "Borderline Personality Disorder", Channel 13, Baltimore, Md., 9/16 and 9/17/93 (with Sandra Pinkney).
  22. "Borderline Personality Disorder", Video Medical News, Ivanhoe Communications. (Broadcast in over 150 cities in U.S. and Canada, 1993 - 1996).

BIBLIOGRAPHY:

  1. Uhlenhuth, E.H. and Park, L.C. "The influence of medication (imipramine) and doctor in relieving depressed psychoneurotic outpatients. " J. Psychiat. Res. 2:101-122, 1964.
  2. Park, L.C. and Lipman, R.S. "A comparison of patient dosage deviation reports with pill counts." Psychopharmacologia 6:299 302, l964.
  3. Fisher, S., Lipman, R.S., Uhlenhuth, E.H., Rickels, K. and Park, L.C. "Drug effects and initial severity of symptomatology." Psychopharmacologia 7:57-60, l965.
  4. Park, L.C. and Covi, L. "Non-blind placebo trial: An exploration of neurotic patients' responses to placebo when its inert content is disclosed." Arch. Gen. Psychiat. 12:336-345, l965.
  5. Lipman, R.S., Hammer, H. M., Bernardes, J.F., Park, L.C. and Cole, J.O. "Patient report of significant life situation events: Methodological implications for outpatient drug evaluation." Dis. Nerv. Syst. 26: 586-591, l965.
  6. Park, L.C., Baldessarini, R.J. and Kety, S.S. "Methionine effects on chronic schizophrenics: Patients treated with monoamine oxidase inhibitors." Arch. Gen. Psychiat. 21:346-351, l965
  7. Uhlenhuth, E.H., Park, L.C., Lipman. R.S., Rickels, K., Fisher, S. and Mock, J.E. "Dosage deviation and drug effects in drug trials." J. Nerv. Ment. Dis. 141:95-99, l965.
  8. Park, L.C., Uhlenhuth, E.H., Lipman, R.S., Rickels, K. and Fisher, S. "A comparison of doctor and patient improvement ratings in a drug (meprobamate) trial." Brit. J. Psychiat. 111:535-540, l965.
  9. Lipman, R.S., Cole, J.O., Park, L.C. and Rickels, K. "Sensitivity of symptom and nonsympton-focused criteria of outpatient drug efficacy." Amer. J. Psychiat. 122:24-27, l965.
  10. Lipman, R.S., Rickels, K., Uhlenhuth, E.H., Park, L.C. and Fisher, S. "Neurotics who fail to take their drugs." Brit. J. Psychiat. lll: 1042-1049, l965.
  11. Uhlenhuth, E.H., Rickels, K., Fisher, S., Park, L.C., Lipman, R.S. and Mock, J.E. "Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy." Psychopharmacologia 9:392-418, l966.
  12. Lipman, R.S., Park, L.C. and Rickels, K. "Paradoxical influence of a therapeutic side-effect interpretation." Arch. Gen. Psychiat. 15:462-474, l966.
  13. Park, L.C., Slaughter, R., Covi, L. and Kniffin, H.C., Jr. "The subjective experience of the research patient: An investigation of psychiatric outpatients' reactions to the research treatment situation." J. Nerv. Ment. Dis. 143:199-206, l966.
  14. Rickels, K., Snow, L., Uhlenhuth, E.H., Lipman, R.S., Park, L.C. and Fisher, S. "Side reactions on meprobamate and placebo." Dis. Nerv. Syst. 28:39-45, l967.
  15. Park, L.C., Covi, L. and Uhlenhuth, E.H. "Effects of informed consent on research patients and study results." J. Nerv. Ment. Dis., l45:349-357, l967.
  16. Uhlenhuth, E.H., Lipman, R.S., Rickels, K., Fisher, S., Covi, L., and Park, L.C. "Predicting the relief of anxiety with meprobamate: Non-drug factors in the response of psychoneurotic outpatients." Arch. Gen. Psychiat., 19:619-630, l968.
  17. Uhlenhuth, E.H., Duncan, D.B. and Park, L.C. "Some nonpharmacologic modifiers of the response to imipramine in depressed psychoneurotic outpatients: A confirmatory study." In May, P.R.A. and Wittenborn, J.R. (eds.) Psychotropic Drug Response: Advances in Prediction, pp. 155-197, Charles C. Thomas, Springfield, IL., l969.
  18. Covi, L., Park, L.C., Lipman, R.S., Uhlenhuth, E.H. and Rickels, K. "Factors affecting withdrawal response to certain minor tranquilizers." In Cole, J.O. and Wittenborn, J.R. (eds.) Drug Abuse: Social and Psychopharmacological Aspects, pp. 93-108, Charles C. Thomas, Springfield, IL., l969.
  19. Rickels, K., Howard, K., Lipman, R.S., Covi, L., Park, L.C. and Uhlenhuth, E.H. "Differential reliability in rating psychopathology and global improvement." J. Clin. Psychol., 26:320-323, l970.
  20. Imboden, J.B. and Park, LC. "Dissociative Reactions." In Tice's Practice of Medicine, Vol. 10, Chapter 38, pp. l9-24, Harper and Row, Hagerstown, MD., l970.
  21. Rickels, K., Lipman, R.S., Fisher, S., Park, L.C. and Uhlenhuth, E.H. "Is a double-blind clinical trial really double blind? A report of doctors' medication guesses." Psychopharmacologia, 16:329-336, l970.
  22. Park, L.C. and Imboden, J.B. "Clinical and heuristic value of clinical drug research." J. Nerv. Ment. Dis., 151:322-340, l970.
  23. Rickels, K., Lipman, R.S., Park, L.C., Covi, L., Uhlenhuth, E.H. and Mock, J.E. "Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquilizers." Psychopharmnacologia, 20: 128-152, l97l.
  24. Uhlenhuth. E.H., Covi, L., Rickels, K., Lipman, R.S. and Park, L.C. "Predicting the relief of anxiety with meprobamate: An attempt at replication." Arch. Gen. Psychiat., 26: 85-91, l972.
  25. Park, L.C. "What limitations should exist on psychiatric evaluations of individuals done for government and other third parties?" The Maryland Psychiatrist, 1:2, l974.
  26. Meyer, E., Derogatis, L.R., Miller, J.M. Park, L.C. and Whitmarsh, G.A. "Medical Clinic patients with emotional disorders." Psychosomatics, 19:611-619,l978.
  27. Meyer, E., Derogatis, L.R., Miller, M.J., Reading, A.J., Cohen, I.H., Park, L.C. and Whitmarsh, G.A. "Addition of time limited psychotherapy to medical treatment in a general medical clinic." J.Nerv. Ment. Dis., 169:780-790, l98l.
  28. Imboden, J.B. and Park, L.C. "Conversion Reactions." In Spittell, J.A., Jr. (ed.) Clinical Medicine, Chapter 35, pp.l-5, Harper and Row, Philadelphia, PA. l98l.
  29. Park, L.C. and Imboden, J.B. "Dissociative Reactions." In Spittell, J.A., Jr. (ed.) Clinical Medicine, Chapter 36, pp. l-5, Harper and Row, Philadelphia, PA., l98l.
  30. Park, L.C. "The APA Assembly in Action." Maryland Psychiatric Society News, 2:2-3, 1988.
  31. Park, L.C. "Positive outlook enhances `golden years'." Senior Digest, 13:18, 1989.
  32. Park, L.C., Imboden, J.B. Park, T.J., Hulse, S.H. and Unger, H.T. "Giftedness and psychological abuse in BPD." In 1992 New Research Program and Abstracts, p. 174, American Psychiatric Association, Washington, D.C., May, 1992.
  33. Park, L.C. "Psychiatry ignoring child abuse and neglect movement." Psychiatric News, 27:14, l992.
  34. Park, L.C., Imboden, J.B., Park, T.J., Hulse, S.H. and Unger, H.T. "Giftedness and psychological abuse in borderline personality disorder: Their relevance to genesis and treatment." Journal of Personality Disorders, 6: 226-240, 1992.
  35. Park, L.C. "Does this patient need psychiatric referral? Borderline personality disorder is serious, life-threatening, and fairly common, yet it goes unrecognized by most physicians." Hospital Medicine, 30: 36-42, l994. [Reprinted in Tiempos Medicos.]
  36. Park, L.C. and Park, T.J. "Personal Intelligence." In McCallum, M. and Piper, W.E. (eds.) Psychological Mindedness: A Contemporary Understanding, Chapter 6, pp. 133-167, Lawrence Erlbaum Associates, Inc., Mahwah, NJ, 1997.
  37. Park, L.C. "Psychiatry at Johns Hopkins Hospital." In The Maryland Psychiatric Society: Celebrating 50 Years, pp 36, 42, Maryland Psych. Soc., Baltimore, 2000.
  38. Allen, T.E., Liebman, M.C., Park, L.C., and Wimmer, W.C., A Primer on Mental Disorders: A Guide for Educators, Families, and Students, Scarecrow Press, Lanham, MD, 2001.

Contributor (Acknowledged in each of the following articles and books):

  1. AMA Council on Drugs: New and Nonofficial Drugs, J.B. Lippincott Co., Phila. and Montreal, l963.
  2. Fisher, S., Cole, J.O., Rickels, K. and Uhlenhuth, E.H. "Drug-set interaction: The effect of expectations on drug response in outpatients." In Bradley, P.B., Flugel, F. and Hoch, P. (eds.) NeuroPsychopharmacology, Vol.3, pp. l49-l56, Elsevier Publ. Co., Amsterdam, l964.
  3. Williams, H.V., Lipman, R.S., Rickels, K., Covi, L., Uhlenhuth, E.H. and Mattson, N.B. "Replication of symptom distress factors in anxious neurotic outpatients." Multivariate Behavioral Research, 3:199-211, 1968.
  4. Lipman, R.S., Covi, L., Rickels, K., Uhlenhuth, E.H. and Lazar, R. "Selected measures of change in outpatient drug evaluation." In Efron, D.H., Cole, J.O., Levine, J. and Wittenborn, J.R. (eds.) Psychopharmacology: A Review of Progress l957-l967, pp. 249-254, PHS Publication No. l836, Washington, D.C., l968.
  5. Mattson, N.B. Williams, H.V., Rickels, K., Lipman, R.S., and Uhlenhuth, E.H. "Dimensions of symptom distress in anxious neurotic outpatients." Psychopharmacology Bull. 5:19-32, l969.
  6. Wittenborn, J.R., Goldberg, S.C. and May, P.R.A. (eds.) Psychopharmacology and the Individual Patient, Raven Press, New York, NY, l970.
  7. Shaffer, J.W., Nussbaum, K. and Lewis, S.M. "Psychiatric assessment from documentary evidence." Compr. Psychiat., 12:564 571, l97l.
  8. Covi, L, Lipman, R.S., Pattison, J.H., Derogatis, L.R., and Uhlenhuth, E.H. "Length of treatment with anxiolytic sedatives and response to their sudden withdrawal." Acta Psychiat. Scand., 49:51-64, l973.
  9. Meyer, E., Derogatis, L.R. Miller, M.J. and Reading, A. "Hypertension and psychological distress." Psychosomatics, l9:160 168, l978.
  10. Karasu, T.B.(ed.) Treatments of Psychiatric Disorders, A Task Force Report of the American Psychiatric Association, American Psychiatric Press, Inc., Washington, D.C., l989
  11. Reviews of Park et al. "Giftedness and psychological abuse in BPD: Their relevance to genesis and treatment":
    (a) Psychiatric News, 26:25,1991: "Borderline patients perceptive about others' feelings."
    (b) Digest of Neurology and Psychiatry, Jan.-Feb. l993, Series 61, p 15: Review by E.A. Fishe, MLS.
    (c) Mental Health Weekly, 3:4, 1993: "All BPD sufferers were subject to abuse, study finds."
    (d) Straight Forward (Medical and Chirurgical Faculty of MD) 4:11, 1993: "Sensitivity and abuse: A lethal combination."
    (e) Johns Hopkins Physician Update, 7: 3, l994: "The Charismatic Problem."

| previous page |

       

about | books | research | links | contact | home
©2004 Lee Crandall Park, M.D.